255 related articles for article (PubMed ID: 29795047)
1. Saracatinib Inhibits Middle East Respiratory Syndrome-Coronavirus Replication In Vitro.
Shin JS; Jung E; Kim M; Baric RS; Go YY
Viruses; 2018 May; 10(6):. PubMed ID: 29795047
[TBL] [Abstract][Full Text] [Related]
2. Abelson Kinase Inhibitors Are Potent Inhibitors of Severe Acute Respiratory Syndrome Coronavirus and Middle East Respiratory Syndrome Coronavirus Fusion.
Coleman CM; Sisk JM; Mingo RM; Nelson EA; White JM; Frieman MB
J Virol; 2016 Oct; 90(19):8924-33. PubMed ID: 27466418
[TBL] [Abstract][Full Text] [Related]
3. Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture.
de Wilde AH; Jochmans D; Posthuma CC; Zevenhoven-Dobbe JC; van Nieuwkoop S; Bestebroer TM; van den Hoogen BG; Neyts J; Snijder EJ
Antimicrob Agents Chemother; 2014 Aug; 58(8):4875-84. PubMed ID: 24841269
[TBL] [Abstract][Full Text] [Related]
4. Development of Small-Molecule MERS-CoV Inhibitors.
Liang R; Wang L; Zhang N; Deng X; Su M; Su Y; Hu L; He C; Ying T; Jiang S; Yu F
Viruses; 2018 Dec; 10(12):. PubMed ID: 30562987
[TBL] [Abstract][Full Text] [Related]
5. Middle East respiratory syndrome coronavirus infection is inhibited by griffithsin.
Millet JK; Séron K; Labitt RN; Danneels A; Palmer KE; Whittaker GR; Dubuisson J; Belouzard S
Antiviral Res; 2016 Sep; 133():1-8. PubMed ID: 27424494
[TBL] [Abstract][Full Text] [Related]
6. A Novel Frameshifting Inhibitor Having Antiviral Activity against Zoonotic Coronaviruses.
Ahn DG; Yoon GY; Lee S; Ku KB; Kim C; Kim KD; Kwon YC; Kim GW; Kim BT; Kim SJ
Viruses; 2021 Aug; 13(8):. PubMed ID: 34452503
[TBL] [Abstract][Full Text] [Related]
7. 3C-like protease inhibitors block coronavirus replication in vitro and improve survival in MERS-CoV-infected mice.
Rathnayake AD; Zheng J; Kim Y; Perera KD; Mackin S; Meyerholz DK; Kashipathy MM; Battaile KP; Lovell S; Perlman S; Groutas WC; Chang KO
Sci Transl Med; 2020 Aug; 12(557):. PubMed ID: 32747425
[TBL] [Abstract][Full Text] [Related]
8. Middle East respiratory syndrome coronavirus: transmission, virology and therapeutic targeting to aid in outbreak control.
Durai P; Batool M; Shah M; Choi S
Exp Mol Med; 2015 Aug; 47(8):e181. PubMed ID: 26315600
[TBL] [Abstract][Full Text] [Related]
9. Identification and evaluation of potent Middle East respiratory syndrome coronavirus (MERS-CoV) 3CL
Kumar V; Shin JS; Shie JJ; Ku KB; Kim C; Go YY; Huang KF; Kim M; Liang PH
Antiviral Res; 2017 May; 141():101-106. PubMed ID: 28216367
[TBL] [Abstract][Full Text] [Related]
10. Tropism and replication of Middle East respiratory syndrome coronavirus from dromedary camels in the human respiratory tract: an in-vitro and ex-vivo study.
Chan RW; Hemida MG; Kayali G; Chu DK; Poon LL; Alnaeem A; Ali MA; Tao KP; Ng HY; Chan MC; Guan Y; Nicholls JM; Peiris JS
Lancet Respir Med; 2014 Oct; 2(10):813-22. PubMed ID: 25174549
[TBL] [Abstract][Full Text] [Related]
11. Broad-spectrum coronavirus antiviral drug discovery.
Totura AL; Bavari S
Expert Opin Drug Discov; 2019 Apr; 14(4):397-412. PubMed ID: 30849247
[TBL] [Abstract][Full Text] [Related]
12. Repurposing of clinically developed drugs for treatment of Middle East respiratory syndrome coronavirus infection.
Dyall J; Coleman CM; Hart BJ; Venkataraman T; Holbrook MR; Kindrachuk J; Johnson RF; Olinger GG; Jahrling PB; Laidlaw M; Johansen LM; Lear-Rooney CM; Glass PJ; Hensley LE; Frieman MB
Antimicrob Agents Chemother; 2014 Aug; 58(8):4885-93. PubMed ID: 24841273
[TBL] [Abstract][Full Text] [Related]
13. The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus.
Gordon CJ; Tchesnokov EP; Feng JY; Porter DP; Götte M
J Biol Chem; 2020 Apr; 295(15):4773-4779. PubMed ID: 32094225
[TBL] [Abstract][Full Text] [Related]
14. Effect of interferon alpha and cyclosporine treatment separately and in combination on Middle East Respiratory Syndrome Coronavirus (MERS-CoV) replication in a human in-vitro and ex-vivo culture model.
Li HS; Kuok DIT; Cheung MC; Ng MMT; Ng KC; Hui KPY; Peiris JSM; Chan MCW; Nicholls JM
Antiviral Res; 2018 Jul; 155():89-96. PubMed ID: 29772254
[TBL] [Abstract][Full Text] [Related]
15. The influence of interferon-lambda on restricting Middle East Respiratory Syndrome Coronavirus replication in the respiratory epithelium.
Jeon YJ; Gil CH; Jo A; Won J; Kim S; Kim HJ
Antiviral Res; 2020 Aug; 180():104860. PubMed ID: 32565134
[TBL] [Abstract][Full Text] [Related]
16. Middle East respiratory syndrome coronavirus (MERS-CoV) entry inhibitors targeting spike protein.
Xia S; Liu Q; Wang Q; Sun Z; Su S; Du L; Ying T; Lu L; Jiang S
Virus Res; 2014 Dec; 194():200-10. PubMed ID: 25451066
[TBL] [Abstract][Full Text] [Related]
17. Update on therapeutic options for Middle East Respiratory Syndrome Coronavirus (MERS-CoV).
Al-Tawfiq JA; Memish ZA
Expert Rev Anti Infect Ther; 2017 Mar; 15(3):269-275. PubMed ID: 27937060
[TBL] [Abstract][Full Text] [Related]
18. Screening of FDA-Approved Drugs Using a MERS-CoV Clinical Isolate from South Korea Identifies Potential Therapeutic Options for COVID-19.
Ko M; Chang SY; Byun SY; Ianevski A; Choi I; Pham Hung d'Alexandry d'Orengiani AL; Ravlo E; Wang W; Bjørås M; Kainov DE; Shum D; Min JY; Windisch MP
Viruses; 2021 Apr; 13(4):. PubMed ID: 33918958
[TBL] [Abstract][Full Text] [Related]
19. Alternative screening approaches for discovery of Middle East respiratory syndrome coronavirus inhibitors.
LaFemina RL
Antimicrob Agents Chemother; 2014 Aug; 58(8):4251-2. PubMed ID: 24867994
[TBL] [Abstract][Full Text] [Related]
20. Middle East Respiratory Syndrome Coronavirus.
Al-Tawfiq JA; Azhar EI; Memish ZA; Zumla A
Semin Respir Crit Care Med; 2021 Dec; 42(6):828-838. PubMed ID: 34918324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
